Back

Tyrosine kinase inhibitors

30 August 2025 (16:30 - 16:45)
Organised by: Logo
Congress Presentation Part of: Paradigm change in pulmonary hypertension: from bench to bedside Pulmonary Hypertension Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Stephan Rosenkranz

Heart Center at the University of Cologne, Cologne (Germany)

3 More presentations in this session

Presentation thumbnail
Activin signalling inhibitors
Professor V. McLaughlin (Ann Arbor, US)
Slides Video
Presentation thumbnail
Precision medicine in pulmonary arterial hypertension: the right time?
Doctor A. Boucly (Le Kremlin Bicetre, FR)
Slides Video
Presentation thumbnail
Pulmonary artery denervation
Doctor S. Chen (Nanjing, CN)
Slides Video

Access the full session

Session thumbnail
Paradigm change in pulmonary hypertension: from bench to bedside
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Cancer treatment-induced pulmonary arterial hypertension
21 June 2025
thumbnail
Congress Session
Biotherapies in cardiovascular disease: from bench to bedside
31 August 2024
thumbnail
Congress Presentation
State-of-the-art lecture on molecular approaches to the treatment of pulmonary hypertension
27 August 2023
thumbnail
Congress Presentation
Effects of inhaled seralutinib on right ventricular-pulmonary arterial (RV-PA) coupling and right heart function in pulmonary arterial hypertension (PAH)
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources